Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis

Our study, for the first time, identifies distinct gene expression and DNA methylation alterations that differentiate UC from PSC-UC at diagnosis in treatment-naïve pediatric patients. We show the gene expression differences observed between PSC-UC and UC are modulated by intricate molecular mechanisms involving master transcriptional regulator-mediated signaling through transcription factors. These findings suggest the potential utility of these molecular markers as predictive biomarkers for PSC development in UC at an early stage of development. Further validation in larger patient cohorts is warranted.

Authors

Institutions

Publication Details

Journal
Gastro Hep Advances
Published
2024-11-15
DOI
https://doi.org/10.1016/j.gastha.2024.11.002
Citations
1
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis

Alexander Kel, Ciarán McDonnell, Glen A. Doherty, Róisín Stack et al.
1 citations
Gastro Hep Advances
Liver Diseases and Immunity
0.37
article

Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis

Alexander Kel, Ciarán McDonnell, Glen A. Doherty, Róisín Stack, Gráinne Kirwan, Séamus Hussey, Ian Stephens, John O’Brien, Flavia Genua, Anna Dominik, Muhammad Ali, Gregory S. Yochum, Luke Grant, Alejandra Rodríguez-Sosa, Michael McDermot, Sudipto Das, Ololade Lawal
article en
1 citations

Abstract

Our study, for the first time, identifies distinct gene expression and DNA methylation alterations that differentiate UC from PSC-UC at diagnosis in treatment-naïve pediatric patients. We show the gene expression differences observed between PSC-UC and UC are modulated by intricate molecular mechanisms involving master transcriptional regulator-mediated signaling through transcription factors. These findings suggest the potential utility of these molecular markers as predictive biomarkers for PSC development in UC at an early stage of development. Further validation in larger patient cohorts is warranted.

Gastro Hep AdvancesVol. 4(3)
Pennsylvania State University (US), Royal College of Surgeons in Ireland (IE), Children's Health Ireland at Crumlin (IE), St. Vincent's University Hospital (IE), GeneXplain (Germany) (DE), Penn State Milton S. Hershey Medical Center (US)
Royal College of Surgeons in Ireland, Ireland Funds, European Crohn's and Colitis Organisation, Enterprise Ireland, Science Foundation Ireland, Irish Research Council, H2020 Marie Skłodowska-Curie Actions
Zero hunger
Openalex Percentile: Top 35%
Liver Diseases and Immunity
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.